Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewORYZON to give updates on corporate progress in February-March
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today
-
EventBIO International Convention 2023
Plazo de solicitud de la convocatoria de ICEX hasta el 15 de febrero
-
NewBCN HEALTH publishes a study assessing the incidence, mortality and hospital costs of isch...
BCN HEALTH ha publicado el estudio 'Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care' en la revista 'Expert Review of Pharmacoeconomics & Outcomes
-
-
CompanyTELUM THERAPEUTICS
-
NewAn example of collaboration to catch pancreatic cancer as early as possible
Amadix, IOMED and NorayBio have joined forces to develop a predictive algorithm for mass data analysis to reduce the mortality rate of this disease
-
OfferInvestigador/a
-
-
-
-
Offer
Investigador/a
-
-
NewGENESIS Biomed sponsors ITEMAS 2022 Annual Conference Day
The “Instituto de Investigación Biomédica de Córdoba” hosts the event, supported by “Instituto de Salud Carlos III (ISCIII)”, with the sponsorship of “Universidad Carlos III de Madrid”, Cidi Salud and
-
NewAptaTargets awarded €2.5 million grant from Spanish government to evaluate ApTOLL for acut...
The funds are from a competitive call through the 2021 State Programme to Promote Scientific-Technical Research and its Transfer (formerly known as Retos Colaboración).
-
-
-
EventTransfiere 2023
AseBio will play a leading role in Transfiere 2023 with talks and a stand next month in Malaga to showcase the work of biotechnology for the green transition.
-
EventUn día con una #MujerBiotech
AseBio lanza el primer programa para emparejar mujeres estudiantes y profesionales 'biotech' con motivo del Día Mundial de la Mujer y la Niña en la Ciencia que se celebra el 1
-
-
NewCellab CDMO, Cellab's new activity
The Andorran biotech company is working to obtain Good Manufacturing Practices (GMP) during the first half of 2023
-
NewYsios Capital strengthens its team with internal promotions and a new Venture Partner
Jordi Xiol has been promoted to Partner after joining Ysios Capital in 2019 Ysios is also incorporating Sanifit co-founder and CEO Joan Perelló as Venture Partner
